ARTHROMAC is indicated for the treatment of mild-to-moderate osteoarthritis.
• HA concentration:
• HA origin:
• HA molecular weigth:
> 3 million Dalton in the sterilized product
Single intraarticular injection
Pain relief, mobility improvement, cartilage protection
• Duration of effect:
Up to 9 months*
• Primary packaging:
Sterile 3 mL prefilled glass syringe with finger grip
• Secondary packaging:
Sterilized medical grade blister in carton box
Between +2°C and +25°C
• Shelf life:
* depending on several factors such as the severity of the osteoarthritis, the type and size of the affected joint, the patient’s condition and age, the patient’s lifestyle, the patient’s genetic profile and the technique of injection.